According to the latest report by IMARC Group, titled “Population Health Management Market Report by Component (Software, Services), Mode of Delivery (Cloud-based, Web-based, On-premises), End User (Healthcare Providers, Healthcare Payers, Employer Groups, Government Bodies), and Region 2025-2033," the global population health management market reached a value of USD 87.2 Billion in 2024. Population health management (PHM) is a holistic approach to improving clinical health outcomes through enhanced care coordination and patient engagement. It includes comprehensive and authoritative strategies, such as compliance programs, health economics, outcome assessments, healthcare reforms, care coordination, and resource management. PHM assist healthcare providers in identifying and addressing care gaps, promoting wellness through evidence-based decision support, and improving the overall patient experience. It also aids in improving clinical efficiency, ensuring patient-centric care by reducing readmission rates, ensuring appropriate and optimum interventions, and providing real-time monitoring and access to medical information. PHM is a patient-friendly platform that aims to improve the population's health by enhancing health decisions and supporting wellness.
Global Population Health Management Market Trends:
The increasing adoption of information technology (IT) solutions in the healthcare industry is one of the key factors driving the market growth. PHM solutions are widely used for processing clinical, financial, and operational data to improve efficiency and patient care. In addition, it enables data aggregation, risk stratification, care coordination, and patient communication, allowing clinicians to make informed decisions leading to better outcomes and reduced treatment costs. Furthermore, the rising geriatric population prone to chronic and acute medical ailments, such as cardiovascular diseases (CVDs), diabetes, and neurological diseases that require continuous surveillance and patient care, is acting as another growth-inducing factor. Additionally, the integration of big data analytics to improve patient outcomes, enhance care management, and address social determinants of health is providing an impetus to the market growth. Moreover, shifting trends from fee-for-service (FFS) to value-based payment (VBP) in medical reimbursement that requires coordination and communication between clinicians across various specialties to improve the overall quality of care is creating a positive outlook for the market. Other factors, including increasing adoption of the Internet of Things (IoT) in healthcare, favorable initiatives by several governments across the globe to promote public health, and rising preference for personalized medicines, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach USD 346.4 Billion by 2033, exhibiting a CAGR of 15.73% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Component, Mode of Delivery, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Allscripts Healthcare Solutions Inc., Athenahealth Inc., Cerner Corporation, eClinicalWorks, Health Catalyst Inc., International Business Machines Corporation, Koninklijke Philips N.V., Lightbeam Health Solutions, McKesson Corporation, Nextgen Healthcare Inc., Optum Inc. (UnitedHealth Group Incorporated) and Symphony Performance Health Inc. (Press Ganey Associates) |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800